GO:0042627; C:chylomicron; IEA:InterPro.
GO:0034363; C:intermediate-density lipoprotein particle; IEA:Compara.
GO:0034362; C:low-density lipoprotein particle; IEA:Compara.
GO:0034366; C:spherical high-density lipoprotein particle; IEA:Compara.
GO:0034361; C:very-low-density lipoprotein particle; IEA:Compara.
GO:0055102; F:lipase inhibitor activity; IEA:Compara.
GO:0008289; F:lipid binding; IEA:Compara.
GO:0060230; F:lipoprotein lipase activator activity; IEA:Compara.
GO:0016004; F:phospholipase activator activity; IEA:Compara.
GO:0033344; P:cholesterol efflux; IEA:Compara.
GO:0034382; P:chylomicron remnant clearance; IEA:Compara.
GO:0034384; P:high-density lipoprotein particle clearance; IEA:Compara.
GO:0006629; P:lipid metabolic process; IEA:InterPro.
GO:0042953; P:lipoprotein transport; IDA:RGD.
GO:0032375; P:negative regulation of cholesterol transport; IEA:Compara.
GO:0045833; P:negative regulation of lipid metabolic process; IEA:Compara.
GO:0048261; P:negative regulation of receptor-mediated endocytosis; IEA:Compara.
GO:0010916; P:negative regulation of very-low-density lipoprotein particle clearance; IEA:Compara.
GO:0033700; P:phospholipid efflux; IEA:Compara.
GO:0045723; P:positive regulation of fatty acid biosynthetic process; IEA:Compara.
GO:0051006; P:positive regulation of lipoprotein lipase activity; IEA:Compara.
GO:0010518; P:positive regulation of phospholipase activity; IEA:Compara.
GO:0060697; P:positive regulation of phospholipid catabolic process; IEA:Compara.
GO:0010898; P:positive regulation of triglyceride catabolic process; IEA:Compara.
GO:0042493; P:response to drug; IEP:RGD.
GO:0070328; P:triglyceride homeostasis; IEA:Compara.